These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
139 related articles for article (PubMed ID: 20333876)
41. Enzyme replacement therapy for infantile-onset Pompe disease. Chen M; Zhang L; Quan S Cochrane Database Syst Rev; 2017 Nov; 11(11):CD011539. PubMed ID: 29155436 [TBL] [Abstract][Full Text] [Related]
42. Enzyme replacement therapy in classical infantile pompe disease: results of a ten-month follow-up study. Klinge L; Straub V; Neudorf U; Voit T Neuropediatrics; 2005 Feb; 36(1):6-11. PubMed ID: 15776317 [TBL] [Abstract][Full Text] [Related]
43. Bradycardia in a case of type II glycogenosis (Pompe's disease) revealing in early neonatal period. Van Maldergem L; Haumont D; Saurty D; Jauniaux E; Loeb H Acta Clin Belg; 1990; 45(6):412-4. PubMed ID: 1964356 [TBL] [Abstract][Full Text] [Related]
44. [Cardiomuscular lysosomal glycogenosis in adults without known enzyme deficiency. A cause of familial myocardiopathy and lysosomal glycogen overload with normal acid maltase]. Bru P; Pellissier JF; Gatau-Pelanchon J; Faugère G; de Barsy T; Levy S; Gérard R Arch Mal Coeur Vaiss; 1988 Jan; 81(1):109-14. PubMed ID: 3130016 [TBL] [Abstract][Full Text] [Related]
47. The change in the pH 4 and pH 6 forms of alpha-glucosidase in cultured amniotic fluid cells and its implication in prenatal diagnosis of Pompe's disease. Fujimoto A; Fluharty AL Clin Chim Acta; 1978 Dec; 90(2):157-61. PubMed ID: 31251 [TBL] [Abstract][Full Text] [Related]
48. Echocardiographic features in the cardiac type of glycogen storage disease II. Gussenhoven WJ; Busch HF; Kleijer WJ; de Villeneuve VH Eur Heart J; 1983 Jan; 4(1):41-3. PubMed ID: 6572589 [TBL] [Abstract][Full Text] [Related]
49. Identification of a de novo point mutation resulting in infantile form of Pompe's disease. Lin CY; Shieh JJ Biochem Biophys Res Commun; 1995 Mar; 208(2):886-93. PubMed ID: 7695647 [TBL] [Abstract][Full Text] [Related]
50. [Enzyme replacement therapy in a boy with infantile Pompe disease: cardiac follow-up]. Bonnefoy R; Labarthe F; Paoli F; Chantreuil J; Barthez MA; Froissart R; Poinsot J; Chantepie A Arch Pediatr; 2008 Dec; 15(12):1760-4. PubMed ID: 18995995 [TBL] [Abstract][Full Text] [Related]
51. Variable Genotype-Phenotype Correlation of Pompe's Disease Caused by a c.2015 G > A (p.Arg672Gln) Mutation in the GAA Gene. Tokatly Latzer I; Sagi L; Bali DS; Rehder C; Orbach R; Fattal-Valevski A Neuropediatrics; 2021 Dec; 52(6):475-479. PubMed ID: 33578445 [TBL] [Abstract][Full Text] [Related]
52. Amniotic cell 4-methylumbelliferyl-alpha-glucosidase activity for prenatal diagnosis of Pompe's disease. Fensom AH; Benson PF; Blunt S; Brown SP; Coltart TM J Med Genet; 1976 Apr; 13(2):148-9. PubMed ID: 1064728 [TBL] [Abstract][Full Text] [Related]
53. Pompe's disease in Chinese and prenatal diagnosis by determination of alpha-glucosidase activity. Lin CY; Hwang B; Hsiao KJ; Jin YR J Inherit Metab Dis; 1987; 10(1):11-7. PubMed ID: 3106710 [TBL] [Abstract][Full Text] [Related]
54. [Pompe and his disease]. van Gijn J; Gijselhart JP Ned Tijdschr Geneeskd; 2011; 155():A2878. PubMed ID: 21649946 [TBL] [Abstract][Full Text] [Related]
55. Human acid alpha-glucosidase from rabbit milk has therapeutic effect in mice with glycogen storage disease type II. Bijvoet AG; Van Hirtum H; Kroos MA; Van de Kamp EH; Schoneveld O; Visser P; Brakenhoff JP; Weggeman M; van Corven EJ; Van der Ploeg AT; Reuser AJ Hum Mol Genet; 1999 Nov; 8(12):2145-53. PubMed ID: 10545593 [TBL] [Abstract][Full Text] [Related]
56. The generation of induced pluripotent stem cells (iPSCs) from patients with infantile and late-onset types of Pompe disease and the effects of treatment with acid-α-glucosidase in Pompe's iPSCs. Higuchi T; Kawagoe S; Otsu M; Shimada Y; Kobayashi H; Hirayama R; Eto K; Ida H; Ohashi T; Nakauchi H; Eto Y Mol Genet Metab; 2014 May; 112(1):44-8. PubMed ID: 24642446 [TBL] [Abstract][Full Text] [Related]
57. A randomized study of alglucosidase alfa in late-onset Pompe's disease. van der Ploeg AT; Clemens PR; Corzo D; Escolar DM; Florence J; Groeneveld GJ; Herson S; Kishnani PS; Laforet P; Lake SL; Lange DJ; Leshner RT; Mayhew JE; Morgan C; Nozaki K; Park DJ; Pestronk A; Rosenbloom B; Skrinar A; van Capelle CI; van der Beek NA; Wasserstein M; Zivkovic SA N Engl J Med; 2010 Apr; 362(15):1396-406. PubMed ID: 20393176 [TBL] [Abstract][Full Text] [Related]
58. Biosynthesis of acid alpha-glucosidase in late-onset forms of glycogenosis type II (Pompe's disease). Steckel F; Gieselmann V; Waheed A; Hasilik A; von Figura K; Oude Elferink R; Kalsbeek R; Tager JM FEBS Lett; 1982 Dec; 150(1):69-76. PubMed ID: 6761145 [TBL] [Abstract][Full Text] [Related]
59. Pompe's disease and anaesthesia. McFarlane HJ; Soni N Anaesthesia; 1986 Dec; 41(12):1219-24. PubMed ID: 3468810 [TBL] [Abstract][Full Text] [Related]
60. Secondary hypertrophic cardiomyopathy in infancy and childhood. Alday LE; Moreyra E Am Heart J; 1984 Oct; 108(4 Pt 1):996-1000. PubMed ID: 6237568 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]